Companies · Software / Tech

NextHealth Technologies, Inc.

DENVER · Software / Tech · refined from filed group “Other Technology

Diligence memoA one-page analyst read on NextHealth Technologies, Inc. — recommendation, valuation, rhythm, risks.
$30.3M
Total raised · real
5
Rounds
0.2×
Latest step-up
Top 15%
Sector rank · raised
Series B
Latest stage · inferred · Fri Sep 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

NextHealth Technologies, Inc. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the technology sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.11× the median modeled value of Series B Software / Tech companies in 2019–2021 (142 peers) — value vs value, same stage and era.
Dormant
  • Last raise 4.8 yr ago; this sector typically re-raises about every 13 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Software / Tech

NextHealth Technologies, Inc. is one of 3920 Software / Tech companies tracked from DENVER. By capital raised it ranks in the upper tier (ahead of 86% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
6
Investors (latest)
2016
Year incorporated
2021-09-10
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BPre-Seed · 2014-07-01 Raised $620K (real) Modeled valuation $26M (est)$620K$26MPre-Seed2014Series A · 2016-08-03 Raised $8.4M (real) Modeled valuation $234M (est)$8.4M$234MSeries A2016Series A · 2018-07-23 Raised $1.4M (real) Modeled valuation $39M (est)$1.4M$39MSeries A2018Series B · 2019-02-15 Raised $17M (real) Modeled valuation $512M (est)$17M$512MSeries B2019Series B · 2021-09-10 Raised $3.0M (real) Modeled valuation $60M (est)$3.0M$60MSeries B2021+$8.4M+$1.4M+$17M+$3.0MCumulative $30M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$620K · 2014
Series A$8.4M · 2016no Seed on file
Series A extension$1.4M · 2018
Series B$16.8M · 2019
Series B extension$3.0M · 2021

Stages are modeled from round size (public records carry no series label). No record for: Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.

Modeled valuation trajectory
$60.1M
Base estimate est.
$7.3M
Conservative case
$184.1M
Upside case
$16.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the technology sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $26.3M · 2014-07-012014Series A · modeled $233.9M · 2016-08-03Series A · modeled $39.3M · 2018-07-23Series B · modeled $512.5M · 2019-02-15Series B · modeled $60.1M · 2021-09-102021
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
67%
Survival probability
44% low · 81% high
1.42×/yr
Annual markup
1.72×/yr upside case
4.8 yr
Elapsed time used
4.8 yr actual, capped for stale marks
technology
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
22 mo
Avg between rounds
$4.2M/yr
Capital velocity
12.0 yr
On record since
2014
First round
5
Rounds on file
How it compares to the market

Benchmarked against 3920 companies in Software / Tech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 6.6× above median
This company$30.3M
Sector median$4.6M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.2× of median
This company$3.0M
Sector median$19.9M
Modeled value — vs sector median (estimate, all stages) 1.6× above median
This company$60.1M
Sector median$36.6M

Raised more than 86% of sector peers (real $). Modeled value above 62% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #137 of 142.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0B$10.0M$100.0MCapital raised (log)Trackonomy Systems, Inc. · Series B Raised $49.2M · modeled $1.2B (est)Tray.IO Inc. · Series B Raised $59.3M · modeled $1.1B (est)Unravel Data Systems, Inc. · Series B Raised $56.2M · modeled $1.1B (est)Salus Labs, Inc. · Series B Raised $35.0M · modeled $1.1B (est)Anchor Labs, Inc. · Series B Raised $33.7M · modeled $1.0B (est)Compound Labs, Inc. · Series B Raised $41.8M · modeled $1.0B (est)Mode Analytics, Inc. · Series B Raised $72.3M · modeled $996.8M (est)Cleo Labs, Inc · Series B Raised $84.7M · modeled $958.4M (est)Bevy Labs, Inc. · Series B Raised $55.0M · modeled $956.5M (est)Temperpack Technologies Inc. · Series B Raised $79.9M · modeled $940.4M (est)Hound Labs, Inc. · Series B Raised $49.2M · modeled $933.9M (est)Cloud Elements, Inc. · Series B Raised $60.2M · modeled $913.7M (est)NextHealth Technologies, Inc. (this company) Raised $30.3M · modeled $60.1M (est)NextHealth Technologies, Inc.
CompanyStageRaised · realValue · estvs peer med.
Trackonomy Systems, Inc.Series B$49.2M$1.2B2.16×
Tray.IO Inc.Series B$59.3M$1.1B2.06×
Unravel Data Systems, Inc.Series B$56.2M$1.1B1.95×
Salus Labs, Inc.Series B$35.0M$1.1B1.95×
Anchor Labs, Inc.Series B$33.7M$1.0B1.88×
Compound Labs, Inc.Series B$41.8M$1.0B1.84×
Mode Analytics, Inc.Series B$72.3M$996.8M1.83×
Cleo Labs, IncSeries B$84.7M$958.4M1.76×
Bevy Labs, Inc.Series B$55.0M$956.5M1.75×
Temperpack Technologies Inc.Series B$79.9M$940.4M1.72×
Hound Labs, Inc.Series B$49.2M$933.9M1.71×
Cloud Elements, Inc.Series B$60.2M$913.7M1.67×
NextHealth Technologies, Inc. this companySeries B$30.3M$60.1M0.11×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$620K2014-07-01$3.4M$26.3M85%
Series A$8.4M2016-08-03$38.3M$233.9M85%
Series A$1.4M2018-07-23$6.4M$39.3M90%
Series B$16.8M2019-02-15$93.5M$512.5M90%
Series B$3.0M2021-09-10$16.7M$60.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$620K2014-07-01
    • First recorded raise — entered as Pre-Seed.
  2. Series A$8.4M2016-08-03
    • Raised again after 25 mo — slower than the ~13 mo sector norm.
    • Round 13.6× larger than the prior — scaling up.
    • 11 investors on this round.
  3. Series A$1.4M2018-07-23
    • Raised again after 24 mo — slower than the ~13 mo sector norm.
    • Round 6.0× smaller than the prior — bridge or down round.
    • 7 investors on this round.
  4. Series B$16.8M2019-02-15
    • Came back fast: 7 mo vs the ~13 mo sector norm.
    • Round 11.9× larger than the prior — scaling up.
    • 9 investors on this round.
  5. Series B$3.0M2021-09-10
    • Raised again after 31 mo — slower than the ~13 mo sector norm.
    • Round 5.6× smaller than the prior — bridge or down round.
    • 6 investors on this round.
Intelligence
2023 ~Q2
Modeled next raise · ~22mo cadence
$3.0M
Modeled next size est.range $3.0M$4.8M
0.2×
Last step-up
$4.2M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
David Klein9 other2018-07
Casper De Clercq8 other2016-08
Anne Marie Aponte1 other2019-02
Ryan Engle1 other2019-02
Aria Ward2021-09
Cynthia Nustad2021-09
Daniel Spirek2016-08
Earl Devanny III2018-07
Eric Grossman2014-07
Jeff Maxwell2019-02
Marla Dugger2016-08
Mehrshad Setayesh2021-09
Melissa O'Connor2019-02
Nasir Ali2021-09
Peter Everett2016-08
Ron Villarreal2019-02
Sonu Kansal2019-02
Registry & provenance

NextHealth Technologies, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1602245
SEC CIK
2016
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Vbrick Systems IncSoftware / TechSeries B$30.5M$73.5Msame sector · same stage
Morpheus Data Holdings, LLCSoftware / TechSeries B$30.8M$63.6Msame sector · same stage
Sparta Software CorpSoftware / TechSeries B$31.8M$54.7Msame sector · same stage
Electric Era Technologies, Inc.Software / TechSeries B$33.0M$45.1Msame sector · same stage
Compact Membrane Systems, Inc.Software / TechSeries B$26.8M$47.1Msame sector · same stage
D3 Technology, Inc.Software / TechSeries B$36.4M$44.3Msame sector · same stage
Devolver Digital, Inc.Software / TechSeries B$36.5M$47.9Msame sector · same stage
SingleFile Technologies Inc.Software / TechSeries B$24.2M$55.1Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Next Healthcare Inc.HealthtechPre-Seed$8.1M89%
CloudHealth Technologies, Inc.Software / TechSeries C$1.4B88%
Better Health Technologies Inc.HealthtechSeries A$211.9M86%
Healthcare, Inc.HealthtechSeries D+$4.0B85%
Healthe, Inc.HealthtechSeries B$465.2M85%
nextmv.io inc.Software / TechSeries A$262.8M85%
Youme Healthcare, Inc.HealthtechSeries A$9.4M84%
Healthie Inc.HealthtechSeed$29.8M84%
Frequently asked
How much funding has NextHealth Technologies, Inc. raised?
NextHealth Technologies, Inc. has raised approximately $30.3M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is NextHealth Technologies, Inc.'s estimated valuation?
Provath's modeled valuation for NextHealth Technologies, Inc. is approximately $60.1M (modeled range $7.3M–$184.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is NextHealth Technologies, Inc. at?
NextHealth Technologies, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Fri Sep 10.
What does NextHealth Technologies, Inc. do and where is it based?
NextHealth Technologies, Inc. operates in the Software / Tech sector, based in DENVER.
Explore related

See where NextHealth Technologies, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at NextHealth Technologies, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.